|
|
Glycosylation of dentin matrix protein 1 is a novel key element for astrocyte maturation and BBB integrity |
Bo Jing1, Chunxue Zhang1, Xianjun Liu1, Liqiang Zhou1, Jiping Liu1, Yinan Yao1, Juehua Yu1, Yuteng Weng2, Min Pan2, Jie Liu1, Zuolin Wang2(), Yao Sun2(), Yi Eve Sun1,3,4() |
1. Tongji University School of Medicine, Stem Cell Translational Research Center, Tongji Hospital, Shanghai 200065, China 2. Department of Oral Implantology, School of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai 200072, China 3. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA 4. Collaborative Innovation Center for Brain Science, Tongji University, Shanghai 200092, China |
|
|
Abstract The blood-brain barrier (BBB) is a tight boundary formed between endothelial cells and astrocytes, which separates and protects brain from most pathogens as well as neural toxins in circulation. However, detailed molecular players involved in formation of BBB are not completely known. Dentin matrix protein 1 (DMP1)-proteoglycan (PG), which is known to be involved in mineralization of bones and dentin, is also expressed in soft tissues including brain with unknown functions. In the present study, we reported that DMP1-PG was expressed in brain astrocytes and enriched in BBB units. The only glycosylation site of DMP1 is serine89 (S89) in the N-terminal domain of the protein in mouse. Mutant mice with DMP1 point mutations changing S89 to glycine (S89G), which completely eradicated glycosylation of the protein, demonstrated severe BBB disruption. Another breed of DMP1 mutant mice, which lacked the C-terminal domain of DMP1, manifested normal BBB function. The polarity of S89G-DMP1 astrocytes was disrupted and cell-cell adhesion was loosened. Through a battery of analyses, we found that DMP1 glycosylation was critically required for astrocyte maturation both in vitro and in vivo. S89G-DMP1 mutant astrocytes failed to express aquaporin 4 and had reduced laminin and ZO1 expression, which resulted in disruption of BBB. Interestingly, overexpression of wild-type DMP1-PG in mouse brain driven by the nestin promoter elevated laminin and ZO1 expression beyond wild type levels and could effectively resisted intravenous mannitol-induced BBB reversible opening. Taken together, our study not only revealed a novel element, i.e., DMP1-PG, that regulated BBB formation, but also assigned a new function to DMP1-PG.
|
Keywords
blood-brain barrier
dentin matrix protein1
glycosylation
astrocyte
cell adhesion
proteoglycan
|
Corresponding Author(s):
Zuolin Wang,Yao Sun,Yi Eve Sun
|
Issue Date: 21 March 2018
|
|
1 |
Alvarez JIet al. (2011) The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334 (6063):1727–1731
https://doi.org/10.1126/science.1206936
|
2 |
Armulik Aet al. (2010) Pericytes regulate the blood-brain barrier. Nature 468(7323):557–561
https://doi.org/10.1038/nature09522
|
3 |
Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468(7321):232–243
https://doi.org/10.1038/nature09613
|
4 |
Bell RD, Winkler EA, Singh I, Sagare AP, Deane Ret al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485:512–516
https://doi.org/10.1038/nature11087
|
5 |
Bhattacharjee AKet al. (2001) The effects of the Na+/Ca++ exchange blocker on osmotic blood–brain barrier disruption. Brain Res 900 (2):157–162
https://doi.org/10.1016/S0006-8993(01)02253-3
|
6 |
Dalkara T, Alarcon-Martinez L (2015) Cerebral microvascular pericytes and neurogliavas-cular signaling in health and disease. Brain Res 1623:3–17
https://doi.org/10.1016/j.brainres.2015.03.047
|
7 |
Deane R, Sagare A, Hamm K, Parisi M, Lane Set al.(2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Investig 118:4002–4013
https://doi.org/10.1172/JCI36663
|
8 |
Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagacé M, Kuan WLet al. (2015) Cerebrovascular and blood-brain barrier impairments in Huntington’s disease: potential implications for its pathophysiology. Ann Neurol 78:160–177
https://doi.org/10.1002/ana.24406
|
9 |
Feng JQet al. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38(11):1310–1315
https://doi.org/10.1038/ng1905
|
10 |
George A, Sabsay B, Simonian PA, Veis A (1993) Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem 268(17):12624–12630
|
11 |
George A, Silberstein R, Veis A (1995) In situ hybridization shows Dmp1 (AG1) to be a developmentally regulated dentin-specific protein produced by mature odontoblasts. Connect Tissue Res 33(1–3):67–72
https://doi.org/10.3109/03008209509016984
|
12 |
Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CAet al. (2016) Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 36:216–227
https://doi.org/10.1038/jcbfm.2015.44
|
13 |
Huang YA, Zhou B, Wernig M, Südhof TC (2017) ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ secretion. Cell 168:427–441
https://doi.org/10.1016/j.cell.2016.12.044
|
14 |
Knowland Det al. (2014) Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82(3):603–617
https://doi.org/10.1016/j.neuron.2014.03.003
|
15 |
Korczyn AD (2015) Vascular parkinsonism–characteristics, pathogenesis and treatment. Nat Rev Neurol 11:319–326
https://doi.org/10.1038/nrneurol.2015.61
|
16 |
Lorenz-Depiereux Bet al. (2006) DMP1 mutations in autosomal recessive hypophosphate-mia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38 (11):1248–1250
https://doi.org/10.1038/ng1868
|
17 |
Menezes MJet al.(2014) The extracellular matrix protein laminin α2 regulates the maturation and function of the blood-brain barrier. J Neurosci 34(46):15260–15280
https://doi.org/10.1523/JNEUROSCI.3678-13.2014
|
18 |
Pan GYet al. (2000) Intracarotid infusion of hypertonic mannitol changes permeability of blood brain barrier to methotrexate in rats. Acta Pharmacol Sin 21(7):613–616
|
19 |
Peng Tet al. (2008) Blocking of proteolytic processing and deletion of glycosaminoglycan side chain of mouse DMP1 by substituting critical amino acid residues. Cells Tissues Organs 189(1–4):192–197
|
20 |
Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood–brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1(3):223–236
https://doi.org/10.1007/s11481-006-9025-3
|
21 |
Qin Cet al. (2006) A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment. J Biol Chem 281 (12):8034–8040
https://doi.org/10.1074/jbc.M512964200
|
22 |
Romero IAet al. (2003) Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344:112–116
https://doi.org/10.1016/S0304-3940(03)00348-3
|
23 |
Rowe PSNet al. (2000) MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67(1):54–68
https://doi.org/10.1006/geno.2000.6235
|
24 |
Sun Yet al. (2015) Glycosylation of Dentin Matrix Protein 1 is critical for osteogenesis. Sci Rep 5:17518
https://doi.org/10.1038/srep17518
|
25 |
Sweeney MD, Sagare AP, Zlokovic BV (2015) Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer’s disease. J Cereb Blood Flow Metab 35:1055–1068
https://doi.org/10.1038/jcbfm.2015.76
|
26 |
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler Tet al. (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11:457–470
https://doi.org/10.1038/nrneurol.2015.119
|
27 |
Terasawa M, Shimokawa R, Terashima T, Ohya K, Takagi Y, Shimokawa H (2004) Expression of dentin matrix protein 1 (DMP1) in nonmineralized tissues. J Bone Miner Metab 22 (5):430–438
https://doi.org/10.1007/s00774-004-0504-4
|
28 |
Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SHet al. (2013) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 125:111–120
https://doi.org/10.1007/s00401-012-1039-8
|
29 |
Wolburg H, Lippoldt A (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc Pharmacol 38:323–337
https://doi.org/10.1016/S1537-1891(02)00200-8
|
30 |
Yao Y, Chen Z-L, Norris EH, Strickland S (2014) Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 5:3413
https://doi.org/10.1038/ncomms4413
|
31 |
Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163:1064–1078
https://doi.org/10.1016/j.cell.2015.10.067
|
32 |
Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares Ret al. (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease. Neurobiol Aging 28:977–986
https://doi.org/10.1016/j.neurobiolaging.2006.05.016
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|